Prescription ID | TCMF2142 |
Pinyin Name | Qing Qi Hua Tan Wan |
Chinese Name | 清气化痰丸 |
English Name | Qi Clearing Phlegm Dissolving pills |
Function Description | 咳嗽 |
Indications | None |
Disease ICD-11 Category | |
Human Tissues Associated with Indication | Lung |
Reference | Chinese Classical Prescriptions |
Reference Book/link | ISBN 7-5023-3930-2 |
Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
---|---|---|---|---|
TCMH404 | Rhizoma arisaema cum bile | 胆南星 | TCMH404 | |
TCMH705 | Trichosanthes kirilowii | 瓜蒌 | TCMH705 | ITSAO4359-14 |
TCMH130 | Pinellia ternata | 半夏 | TCMH130 | GBVT1123-13, GBVY1693-14 |
TCMH1184 | Citrus reticulata | 橘皮 | TCMH1184 | ITSAA1245-14 |
TCMH986 | Scutellaria baicalensis | 黄芩 | TCMH986 | ITSAP4211-14 |
TCMH1219 | Semen armeniacae amarum | 苦杏仁 | TCMH1219 | |
TCMH2630 | Citrus aurantium | 枳实 | TCMH2630 | ITSAA1279-14 |
TCMH606 | Wolfiporia cocos | 茯苓 | TCMH606 | GBPOL314-13 |
TCMH1903 | Zingiber officinale | 生姜 | TCMH1903 | ITSAO3969-14 |
Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
---|---|---|---|---|
TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
TCMT17 | POLB | DNA polymerase beta | Transferase | P06746 |
TCMT208 | MAOA | Monoamine oxidase A | Oxidoreductase | P21397 |
TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
TCMT221 | ABCB11 | Bile salt export pump | Transporter | O95342 |
TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
TCMT240 | AMY1A | Salivary alpha-amylase | Unclassified | P04745 |
TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
TCMT283 | PTPRS | Receptor-type tyrosine-protein phosphatase S | Hydrolase | Q13332 |
TCMT289 | TBXAS1 | Thromboxane-A synthase | Isomerase | P24557 |
TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
TCMT301 | PTGES | Prostaglandin E synthase | Isomerase | O14684 |
TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
TCMT316 | MTNR1A | Melatonin receptor 1A | GPCR | P48039 |
TCMT317 | MTNR1B | Melatonin receptor 1B | GPCR | P49286 |
TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
TCMT337 | XPO1 | Exportin-1 | Unclassified | O14980 |
TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
TCMT561 | NT5E | 5'-nucleotidase | Hydrolase | P21589 |
TCMT565 | EP300 | Histone acetyltransferase p300 | Transferase | Q09472 |
TCMT571 | ADORA2B | Adenosine A2b receptor | GPCR | P29275 |
TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
TCMT61 | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Unclassified | Q07820 |
TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
TCMT636 | POLA1 | DNA polymerase alpha subunit | Transferase | P09884 |
TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
TCMT801 | TUBB3 | Tubulin beta-3 chain | Unclassified | Q13509 |
TCMT807 | SLC22A12 | Solute carrier family 22 member 12 | Transporter | Q96S37 |
TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
Target ID | Target Name |
---|---|
TCMT1175 | Human immunodeficiency virus |
TCMT1176 | Streptococcus pneumoniae |
TCMT1178 | Actinomyces viscosus |
TCMT1181 | Mycobacterium tuberculosis H37Ra |
TCMT1188 | Leishmania braziliensis |
TCMT1189 | Pseudomonas fluorescens |
TCMT1191 | Bacillus megaterium |
TCMT1207 | Legionella pneumophila |
TCMT1208 | Escherichia coli K12 |
TCMT1209 | Staphylococcus haemolyticus |
TCMT1210 | Streptococcus sobrinus |
TCMT1211 | Fusobacterium nucleatum |
TCMT1212 | Verticillium dahliae |
TCMT1213 | Neisseria gonorrhoeae |
TCMT1214 | Enterococcus faecium |
TCMT1217 | Bacillus anthracis |
TCMT1218 | Staphylococcus aureus |
TCMT1221 | Human herpesvirus 4 |
TCMT1222 | Plasmodium falciparum D6 |
TCMT1223 | Staphylococcus epidermidis |
TCMT1226 | Klebsiella pneumoniae |
TCMT1229 | Enterococcus faecalis |
TCMT1232 | Pseudomonas aeruginosa |
TCMT1236 | Mycobacterium bovis |
TCMT1245 | Phytophthora cactorum |
TCMT1246 | Escherichia coli |
TCMT1249 | Dengue virus 2 |
TCMT1251 | Candida albicans |
TCMT1253 | Penicillium chrysogenum |
TCMT1255 | Human immunodeficiency virus 1 |
TCMT1260 | Streptococcus agalactiae |
TCMT1283 | Human enterovirus 71 |
TCMT1286 | Bacillus cereus |
TCMT1294 | Human parainfluenza virus 3 |
TCMT1318 | Human T-lymphotropic virus 1 |
TCMT1319 | Corynebacterium xerosis |
TCMT1321 | Staphylococcus hominis |
TCMT1322 | Streptococcus mitis |
TCMT1323 | Corynebacterium pseudodiphtheriticum |
TCMT1324 | Corynebacterium diphtheriae |
TCMT1343 | Staphylococcus simulans |
TCMT1344 | Staphylococcus sciuri |
TCMT1346 | Helicobacter pylori |
TCMT1349 | Helicobacter pylori SS1 |
TCMT1361 | Neisseria meningitidis |
TCMT1370 | Prevotella melaninogenica |
TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
TCMT1393 | Vibrio sp. |
TCMT1408 | Colletotrichum gloeosporioides |
TCMT1410 | Listeria monocytogenes |
TCMT1412 | Salmonella typhimurium |
TCMT1438 | Plasmodium falciparum |
TCMT1439 | Mycobacterium smegmatis |
TCMT1442 | Leishmania donovani |
TCMT1443 | Leishmania amazonensis |
TCMT1444 | Fusarium oxysporum |
TCMT1448 | Enterobacter aerogenes |
TCMT1449 | Influenza A virus |
TCMT1454 | Bacillus subtilis |
TCMT1455 | Mycobacterium tuberculosis H37Rv |
TCMT1458 | Filobasidiella neoformans |
TCMT1462 | Streptococcus mutans |
TCMT1463 | Mycobacterium tuberculosis |
TCMT1464 | Hepatitis B virus |
TCMT1465 | Entamoeba histolytica |
GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
---|---|---|---|
[BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA, PTGES, TBXAS1, TRPV1 | 7.31529 |
[BP] GO:0065008 | regulation of biological quality | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FLT3, HSD17B1, HSD17B2, KDR, MAOA, MCL1, MET, MTNR1B, POLA1, POLB, PPARA, SRC, TNKS, TNKS2, TRPV1, XDH | 6.86681 |
[BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.86681 |
[BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MCL1, MMP2, POLB, PPARA, PTGES, SRC, TRPV1, TYR | 6.73745 |
[BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 | 6.36431 |
[BP] GO:0042221 | response to chemical | ABCB1, AKR1B1, ALOX15, ALPL, AXL, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MCL1, MMP2, MMP9, POLB, PPARA, PTGES, SRC, TRPV1, TYR | 6.36431 |
[BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, AXL, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, HSD17B2, IGF1R, MMP2, MMP9, POLB, PPARA, PTGES, SRC, TRPV1, TYR | 6.33341 |
[BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 | 6.19867 |
[BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 | 5.98453 |
[BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 5.90421 |
[BP] GO:0044281 | small molecule metabolic process | AKR1B1, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, PIM1, PPARA, PTGES, TBXAS1, TYR, XDH | 5.84978 |
[BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PTGES, SRC | 5.03187 |
[BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES, TBXAS1 | 4.81606 |
[BP] GO:0033993 | response to lipid | ALPL, AXL, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, PTGES, SRC, TYR | 4.78738 |
[BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 | 4.78738 |
[BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, PTGES, TBXAS1 | 4.78738 |
[BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, PTGES, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH | 4.58771 |
[BP] GO:0055114 | oxidation-reduction process | AKR1B1, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, MAOA, NQO2, TBXAS1, TYR, XDH | 4.58494 |
[BP] GO:0015711 | organic anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 | 4.58494 |
[BP] GO:0044255 | cellular lipid metabolic process | ACHE, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MET, PPARA, PTGES, TBXAS1 | 4.22299 |
[BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CBR1, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, FUT7, HSD17B2, KDR, MCL1, MET, MMP2, MMP9, PIM1, POLB, PPARA, PTPRS, SRC, TNKS2, TYR | 4.14477 |
[BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, KDR, MCL1, MET, MMP12, MMP9, SRC, TNKS, TNKS2, XDH | 4.09423 |
[BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, KDR, MCL1, MET, MMP12, MMP9, SRC, TNKS, TNKS2, XDH | 4.0782 |
[BP] GO:0019748 | secondary metabolic process | AKR1B1, CYP1A1, CYP1A2, CYP1B1, TYR | 3.64406 |
[BP] GO:0006820 | anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 | 3.58609 |
[BP] GO:0050896 | response to stimulus | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MCL1, MMP12, MMP2, MMP9, POLA1, POLB, PPARA, PTGES, SRC, TRPV1, TYR | 3.48242 |
[BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP2, NQO2, PIM1, POLA1, POLB, PPARA, PTGES, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH | 3.46934 |
[BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.46492 |
[BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 | 3.43186 |
[BP] GO:0014070 | response to organic cyclic compound | ALPL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FLT3, PTGES, SRC, TRPV1, TYR | 3.3016 |
[BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, CA2, CA7, CDK6, KDR, SRC, TNKS, TNKS2, TRPV1 | 3.29991 |
[BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 | 3.2949 |
[BP] GO:0048513 | animal organ development | ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, POLB, PPARA, PTPRS, SRC, TYR | 3.29285 |
[BP] GO:0032787 | None | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES, TBXAS1 | 3.29285 |
[BP] GO:0042493 | response to drug | ABCB1, AKR1B1, AXL, CA9, CDK6, CYP1A1, CYP1B1, FABP3, KDR, POLB, SRC, TRPV1 | 3.29036 |
[BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, AXL, CA12, CA2, CA7, FABP3, FABP4, FLT3, MCL1, MET, MTNR1B, POLA1, POLB, SRC, TRPV1 | 3.29036 |
[BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, AXL, CA2, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, HSD17B2, KDR, MCL1, MMP9, PIM1, POLB, PPARA, PTPRS, SRC, TYR | 3.29036 |
[BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC | 3.17655 |
[BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, AURKB, AXL, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MCL1, MMP2, MMP9, POLA1, POLB, SRC, TRPV1 | 3.04425 |
[BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7 | 2.98378 |
[BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.98378 |
[BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, CDK6, CSNK2A1, CYP1B1, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGES, SRC, XDH | 2.98378 |
[BP] GO:0009725 | response to hormone | AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, PPARA, SRC, TRPV1 | 2.98378 |
[BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, FLT3, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, SRC, TRPV1, XDH | 2.98378 |
[BP] GO:0009056 | catabolic process | ACHE, ADORA1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH | 2.98378 |
[BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, SRC | 2.98378 |
[BP] GO:0019371 | None | CBR1, PTGES, TBXAS1 | 2.89939 |
[BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, AXL, CDK6, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, SRC, TRPV1 | 2.89939 |
[BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TRPV1 | 2.85901 |
[BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, FABP3, FLT3, IGF1R, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, MTNR1A, PIM1, PPARA, SRC, TNKS, TNKS2, TRPV1, XDH | 2.81572 |
[BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, FLT3, KDR, MCL1, MET, MMP12, MMP9, SRC, TNKS, TNKS2, XDH | 2.81572 |
[BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, FLT3, IGF1R, KDR, MCL1, MET, MMP9, PIM1, SRC, TRPV1, XDH | 2.79987 |
[BP] GO:0019752 | carboxylic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, PTGES, TBXAS1, TYR | 2.74205 |
[BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FLT3, IGF1R, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, MTNR1A, PIM1, PPARA, SRC, TNKS, TNKS2, TRPV1, XDH | 2.73365 |
[BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.72014 |
[BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MCL1, MET, MMP9, PIM1, SRC | 2.70793 |
[BP] GO:0008202 | steroid metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2 | 2.66889 |
[BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, AXL, CDK6, CYP1A1, CYP1B1, FABP4, FLT3, IGF1R, KDR, MMP2, SRC, TRPV1 | 2.62443 |
[BP] GO:0032879 | regulation of localization | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, AXL, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP12, MMP9, MTNR1B, PPARA, SRC, TRPV1 | 2.59492 |
[BP] GO:0009987 | cellular process | ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MCL1, MET, MMP1, MMP12, MMP2, MMP9, MTNR1A, MTNR1B, NQO2, PIM1, POLA1, POLB, PPARA, PTGES, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TUBB3, TYR, XDH | 2.56918 |
[BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, IGF1R, KDR, MCL1, MET, MMP12, MMP9, MTNR1B, PTPRS, SRC, TNKS, TNKS2, XDH | 2.51669 |
[BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, IGF1R, KDR, MCL1, MET, MMP12, MMP9, MTNR1B, PTPRS, SRC, TNKS, TNKS2, XDH | 2.43031 |
[BP] GO:0044236 | multicellular organism metabolic process | MMP1, MMP12, MMP2, MMP9, TRPV1 | 2.42932 |
[BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.41316 |
[BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, AXL, CYP1B1, MMP9, SRC | 2.41316 |
[BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2, MTNR1B | 2.41316 |
[BP] GO:0043436 | oxoacid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, PTGES, TBXAS1, TYR | 2.4044 |
[BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.39564 |
[BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.39564 |
[BP] GO:0035690 | cellular response to drug | AKR1B1, AXL, CDK6, CYP1B1, KDR, SRC, TRPV1 | 2.38404 |
[BP] GO:0008283 | cell proliferation | ABCB1, ACHE, AURKB, CYP1A1, FLT3, MET, PIM1, POLA1, SRC, TYR | 2.38292 |
[BP] GO:0018212 | peptidyl-tyrosine modification | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.38214 |
[BP] GO:0006082 | organic acid metabolic process | ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PIM1, PPARA, PTGES, TBXAS1, TYR | 2.36305 |
[BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, FLT3, IGF1R, KDR, MCL1, MMP9, PIM1, SRC, TRPV1, XDH | 2.33736 |
[BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, KDR, POLB, SRC | 2.33614 |
[BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.28288 |
[BP] GO:1904356 | regulation of telomere maintenance via telomere lengthening | AURKB, SRC, TNKS, TNKS2 | 2.22747 |
[BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, AXL, CYP19A1, CYP1A2, CYP1B1, FABP4, HSD17B2, IGF1R, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TNKS2, TRPV1, TYR | 2.21253 |
[BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.21086 |
[BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, HSD17B1, HSD17B2 | 2.21086 |
[BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, PTGES | 2.20608 |
[BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, POLB, PTPRS, SRC, TNKS, XDH | 2.20608 |
[BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, FABP4, FLT3, KDR, MCL1, MET, MMP12, MMP2, MMP9, SRC, TNKS, TNKS2, XDH | 2.20387 |
[BP] GO:2000021 | regulation of ion homeostasis | ADORA1, CA2, CA7, KDR, SRC, TRPV1 | 2.20387 |
[BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, IGF1R, KDR, MCL1, MMP9, PIM1, SRC | 2.18724 |
[BP] GO:2000573 | positive regulation of DNA biosynthetic process | AURKB, SRC, TNKS, TNKS2 | 2.1548 |
[BP] GO:0030574 | collagen catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.13183 |
[BP] GO:0010038 | response to metal ion | ALOX15, CA2, CYP1A1, CYP1A2, FABP4, MMP9, PTGES | 2.12993 |
[BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.12808 |
[BP] GO:0001101 | response to acid chemical | AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, SRC | 2.11134 |
[BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.07812 |
[BP] GO:0070213 | None | TNKS, TNKS2 | 2.05709 |
[BP] GO:0032847 | regulation of cellular pH reduction | CA2, CA7 | 2.05709 |
[BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.05709 |
[BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, POLB, PTPRS, SRC, TNKS, XDH | 2.00226 |
[CC] GO:0016020 | membrane | ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, FUT7, HSD17B2, IGF1R, KDR, MAOA, MCL1, MET, MMP2, MTNR1A, MTNR1B, PIM1, PTGES, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR | 2.38292 |
[CC] GO:0005641 | nuclear envelope lumen | ALOX5, PTGES | 1.54043 |
[CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, AXL, CA4, CHRM2, FLT3, IGF1R, KDR, MET, MTNR1A, MTNR1B, PTPRS, TRPV1 | 1.48633 |
[CC] GO:0099055 | None | ADORA1, PTPRS | 1.47803 |
[CC] GO:0099699 | None | ADORA1, PTPRS | 1.47803 |
[MF] GO:0003824 | catalytic activity | ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PTGES, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TUBB3, TYR, XDH | 11.7739 |
[MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 10.1914 |
[MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, TBXAS1, TNKS, TYR, XDH | 10.1914 |
[MF] GO:0043167 | ion binding | ABCB1, ACHE, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, PTGES, PTPRS, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TUBB3, TYR, XDH | 9.71217 |
[MF] GO:0016835 | carbon-oxygen lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB | 6.86681 |
[MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.35746 |
[MF] GO:0016491 | oxidoreductase activity | AKR1B1, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, HSD17B2, MAOA, NQO2, TBXAS1, TYR, XDH | 5.61658 |
[MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH | 4.70438 |
[MF] GO:0008144 | drug binding | ABCB1, ACHE, AURKB, AXL, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MET, NQO2, PIM1, PPARA, SRC, TRPV1 | 4.44358 |
[MF] GO:0016829 | lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9, POLB | 4.31438 |
[MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH | 4.24179 |
[MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, NQO2, POLA1, PTGES, SRC, TBXAS1, XDH | 4.06193 |
[MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPL, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, POLA1, POLB, PPARA, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH | 3.9189 |
[MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR | 3.67683 |
[MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, TNKS | 3.5482 |
[MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.51248 |
[MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 3.33786 |
[MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET | 3.30701 |
[MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC, TBXAS1 | 3.10175 |
[MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC, TBXAS1 | 2.97545 |
[MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, MET | 2.93562 |
[MF] GO:0042562 | hormone binding | ACHE, HSD17B1, IGF1R, MTNR1A, NQO2 | 2.81572 |
[MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, TYR | 2.74205 |
[MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1 | 2.6085 |
[MF] GO:0036094 | small molecule binding | ABCB1, ADORA1, AURKB, AXL, CDK6, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, NQO2, PIM1, POLA1, SRC, TRPV1, TUBB3, XDH | 2.55148 |
[MF] GO:0004713 | protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, MET, SRC | 2.42932 |
[MF] GO:0043168 | anion binding | ABCB1, ALOX15, AURKB, AXL, CDK6, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, NQO2, PIM1, PTGES, PTPRS, SRC, TRPV1, TUBB3, XDH | 2.41316 |
[MF] GO:0009055 | electron transfer activity | AKR1B1, CYP19A1, CYP1A2, NQO2, XDH | 2.41316 |
[MF] GO:0004672 | protein kinase activity | AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC | 2.38292 |
[MF] GO:0008502 | None | MTNR1A, MTNR1B | 2.28288 |
[MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, POLA1, POLB, SRC | 2.20608 |
[MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, CBR1, HSD17B1, HSD17B2, XDH | 2.05709 |
KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
---|---|---|
Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 11.5855 |
Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 8.2073 |
Metabolic pathways_Homo sapiens_hsa01100 | CBR1, MAOA, ALOX15, AKR1B1, TYR, CYP19A1, POLA1, FUT7, ALOX5, HSD17B1, TBXAS1, HSD17B2, CYP1A2, CYP1A1, ALPL, XDH, PTGES | 5.95 |
Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP19A1 | 6.1908 |
Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, TBXAS1, PTGES | 4.6282 |
Tryptophan metabolism_Homo sapiens_hsa00380 | MAOA, CYP1A2, CYP1A1, CYP1B1 | 3.9838 |
Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 3.9838 |
Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, IGF1R | 3.4577 |
MicroRNAs in cancer_Homo sapiens_hsa05206 | CDK6, ABCB1, PIM1, CYP1B1, MMP9, MET, MCL1 | 3.4681 |
Pathways in cancer_Homo sapiens_hsa05200 | CDK6, FLT3, MMP1, MMP2, MMP9, MET, IGF1R | 2.959 |
Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | CBR1, CYP1A2, CYP1A1, CYP1B1 | 3.1926 |
Adherens junction_Homo sapiens_hsa04520 | CSNK2A1, SRC, MET, IGF1R | 3.1926 |
PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARA | 3.233 |
Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, MTNR1A, MTNR1B, ADORA3, ADORA1, TRPV1 | 2.959 |
PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, CDK6, KDR, MET, MCL1, IGF1R | 2.5002 |
Chemical carcinogenesis_Homo sapiens_hsa05204 | CBR1, CYP1A2, CYP1A1, CYP1B1 | 3.085 |
Melanoma_Homo sapiens_hsa05218 | CDK6, MET, IGF1R | 2.0992 |
Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.9237 |
Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, MET, IGF1R | 1.7854 |
Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, KDR, MET, IGF1R | 1.7739 |
Estrogen signaling pathway_Homo sapiens_hsa04915 | SRC, MMP2, MMP9 | 1.7739 |
Serotonergic synapse_Homo sapiens_hsa04726 | MAOA, ALOX5, ALOX15 | 1.677 |
Endocytosis_Homo sapiens_hsa04144 | SRC, KDR, MET, IGF1R | 1.5119 |
Hepatitis B_Homo sapiens_hsa05161 | CDK6, SRC, MMP9 | 1.4076 |
Viral carcinogenesis_Homo sapiens_hsa05203 | POLB, CDK6, SRC | 1.1653 |
Glioma_Homo sapiens_hsa05214 | CDK6, IGF1R | 1.2311 |
cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, ADORA1, PPARA | 1.1801 |
Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, ADORA1 | 1.2984 |
Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.2984 |
VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.2564 |
Ras signaling pathway_Homo sapiens_hsa04014 | KDR, MET, IGF1R | 1.0754 |
Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET | 1.2198 |
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.2198 |
Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1 | 1.2311 |
AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | MMP2, PIM1 | 1.0183 |
Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | MAOA, CYP1A2 | 1.2198 |
GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2 | 1.0722 |
Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC, TRPV1 | 1.0327 |
Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET | 0.971 |
Circadian entrainment_Homo sapiens_hsa04713 | MTNR1A, MTNR1B | 1.0478 |
Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2 | 1.2082 |
Gap junction_Homo sapiens_hsa04540 | SRC, TUBB3 | 1.0785 |
Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, ACHE | 0.971 |
Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.1653 |
Tyrosine metabolism_Homo sapiens_hsa00350 | MAOA, TYR | 1.6474 |
Platelet activation_Homo sapiens_hsa04611 | SRC, TBXAS1 | 0.9314 |
Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, ADORA1 | 0.9314 |
Measles_Homo sapiens_hsa05162 | CDK6, CSNK2A1 | 0.8557 |
Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.9322 |
Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2 | 1.7739 |
Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIM1, MCL1 | 0.7804 |
Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.8468 |
Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.8952 |
cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, ADORA1 | 0.7535 |
Purine metabolism_Homo sapiens_hsa00230 | POLA1, XDH | 0.7416 |
Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, SRC | 0.6396 |
HTLV-I infection_Homo sapiens_hsa05166 | POLB | 0.2812 |
Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1 | 0.3534 |
Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2 | 0.3811 |
Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.3754 |
Tuberculosis_Homo sapiens_hsa05152 | SRC | 0.3811 |
Alcoholism_Homo sapiens_hsa05034 | MAOA | 0.3811 |
Apoptosis_Homo sapiens_hsa04210 | MCL1 | 0.4415 |
ErbB signaling pathway_Homo sapiens_hsa04012 | SRC | 0.5137 |
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PPARA | 0.4235 |
Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.3752 |
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | IGF1R | 0.4415 |
Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC | 0.4149 |
Phagosome_Homo sapiens_hsa04145 | TUBB3 | 0.4202 |
Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1 | 0.4415 |
Insulin resistance_Homo sapiens_hsa04931 | PPARA | 0.4887 |
Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.4642 |
Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | IGF1R | 0.5072 |
FoxO signaling pathway_Homo sapiens_hsa04068 | IGF1R | 0.454 |
AMPK signaling pathway_Homo sapiens_hsa04152 | IGF1R | 0.4642 |
TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.4887 |
Prostate cancer_Homo sapiens_hsa05215 | IGF1R | 0.5137 |
Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC | 0.4707 |
Hepatitis C_Homo sapiens_hsa05160 | PPARA | 0.454 |
HIF-1 signaling pathway_Homo sapiens_hsa04066 | IGF1R | 0.501 |
Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.5043 |
Cell cycle_Homo sapiens_hsa04110 | CDK6 | 0.4642 |
Axon guidance_Homo sapiens_hsa04360 | MET | 0.4593 |
Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.5043 |
Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | IGF1R | 0.5109 |
Dopaminergic synapse_Homo sapiens_hsa04728 | MAOA | 0.4574 |
GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.5137 |
Small cell lung cancer_Homo sapiens_hsa05222 | CDK6 | 0.5137 |
Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.5137 |
Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.5137 |
Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5 | 0.4707 |
Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.5137 |
Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.5109 |
NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1 | 0.5109 |
Pyrimidine metabolism_Homo sapiens_hsa00240 | POLA1 | 0.498 |
Pancreatic secretion_Homo sapiens_hsa04972 | CA2 | 0.5109 |
Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.5137 |
Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6 | 0.5522 |
Peroxisome_Homo sapiens_hsa04146 | XDH | 0.5137 |
Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC | 0.5527 |
Gastric acid secretion_Homo sapiens_hsa04971 | CA2 | 0.5518 |
Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | IGF1R | 0.5664 |
Pancreatic cancer_Homo sapiens_hsa05212 | CDK6 | 0.5664 |
Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5586 |
Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.5664 |
Amphetamine addiction_Homo sapiens_hsa05031 | MAOA | 0.5658 |
Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.5772 |
Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5664 |
p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.5592 |
Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5664 |
Non-small cell lung cancer_Homo sapiens_hsa05223 | CDK6 | 0.5936 |
Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B1 | 0.5784 |
Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | TUBB3 | 0.595 |
Malaria_Homo sapiens_hsa05144 | MET | 0.6299 |
Cocaine addiction_Homo sapiens_hsa05030 | MAOA | 0.6299 |
Arginine and proline metabolism_Homo sapiens_hsa00330 | MAOA | 0.6276 |
Drug metabolism - other enzymes_Homo sapiens_hsa00983 | XDH | 0.6396 |
ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.6492 |
Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | MAOA | 0.6819 |
Galactose metabolism_Homo sapiens_hsa00052 | AKR1B1 | 0.7535 |
Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7471 |
DNA replication_Homo sapiens_hsa03030 | POLA1 | 0.7187 |
Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B1 | 0.7416 |
Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B1 | 0.7187 |
Base excision repair_Homo sapiens_hsa03410 | POLB | 0.7416 |
Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.7838 |
Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.7804 |
Histidine metabolism_Homo sapiens_hsa00340 | MAOA | 0.8097 |
Phenylalanine metabolism_Homo sapiens_hsa00360 | MAOA | 0.9314 |
Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.097 |
Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 0.971 |